The SUMMIT trial, conducted by Eli Lilly and published in November 2024, focused on 731 patients with both heart failure (ejection fraction 50%) and obesity
In addition, systematic reviews and meta-analyses of randomized controlled trials report improvements in cardiac systolic and diastolic function in patients with type 2 diabetes, as well as reductions in infarct size after myocardial infarction [163]
Through systematic analysis of clinical trials, meta-analyses, and emerging evidence from landmark studies like SELECT, this paper evaluates whether GLP-1 agonists represent a transformative breakthrough or an overhyped intervention with significant limitations
The body is used to getting 3,000 calories per day, but all of a sudden is only given 2,600 calories a day - that takes a toll
Advanced Blood Sugar Support: Combines Berberine with Chromium Picolinate and Milk Thistle to optimize blood sugar levels, supporting overall metabolic health and energy balance
Continued treatment with Tirzepatide for maintenance of weight reduction in adults with obesity